Unassociated Document
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d)
of
the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): January 26,
2009
MEDCOM USA, INCORPORATED
(Exact
name of registrant as specified in its charter)
Delaware
(State
or other jurisdiction of incorporation)
|
0-25474
|
|
65-0287558
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification
No.)
|
|
PO
Box 90358, Henderson, NV
|
89009
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (877) 763-3729
7975 North Scottsdale Rd., Suite D333, Scottsdale,
AZ 85253
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction A.2
below):
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On
January 20, 2009, the Board of Directors of MedCom USA, Inc (the
“Corporation”) pursuant to Article V Section 4 of the By-Laws of the Corporation
removed William P. Williams.
However,
Michael Malet resigned as the member of the Board of Directors.
On
January 20, 2009, the Board of Directors removed William P. Williams as
President, Chief Executive Officer and Principle Accounting Officer, and removed
Eva Williams as the Secretary and Treasurer of the Corporation.
However,
Michael Malet resigned as Executive Vice President of the
Corporation,
On
January 20, 2009, the Board of Directors appointed Michael Delagarza as a member
of the Board of Directors. On January 20, 2009, the Board of Directors
appointed Michael Delagarza as President and, in accordance with Article V
Section 4 of the By-Laws, Chief Executive Officer of the
Corporation.
Michael
De La Garza’s biography is as follows:
Michael
De La Garza is a health care executive with over 20 years of
experience. His experiences have been most recently in acute care
hospitals serving in CIO/CTO. Mr. De La Garza has been the CEO of
Absolute Medical Software Systems, LLC and PayMed USA, LLC since 2001 through
the present for the past seven (7) years serving as CEO and President. His
experience is also complimented by serving as CEO and administrator of a chain
of diagnostic imaging centers in Texas and surrounding states since 2005. He has
been employed as a healthcare consultant for both profit and not for profit
health care facilities.
Mr. De La
Garza has a thorough understanding of all aspects of operations including the
financial and physician side of the health care environment. He has served as
CEO and founder of five accidents and injury physician clinic comprised of over
15 physicians. Other unique features in his career include serving in
a position of Director of Business Development for a large medical billing
company. He has also been involved in “certificate of need “review processes and
community health planning for the diagnostic imaging centers.
Mr. De La
Garza has developed and operated his own consulting firm. The focus
of his consulting activities was on hospitals and physician practice
development. The consulting areas included regulatory compliance, physician
practice auditing, feasibility studies for imaging facilities and insurance
billing and collection auditing.
Mr. De La
Garza has a technology degree from Danforth College in Texas City, Texas as well
as attending South West Texas State College in San Marcos, Texas.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
99.1
Press Release dated January 26, 2009
99.2
Resignation of Michael Malet
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
|
MEDCOM
USA INCORPORATED
|
|
|
|
|
|
|
Date:
January 27, 2009
|
By:
|
/s/
Michael De La Garza
|
|
|
|
|
Michael
De La Garza
|
|
|
|
|
Chief
Executive Officer; President
|
|